临床试验

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

NCT：NCT05637801 · COMPLETED

NCT编号NCT05637801

状态COMPLETED

开始日期2022-12-13

完成时间2026-08-17

SponsorCognito Therapeutics, Inc. (INDUSTRY)

First posted2022-12-05

Last updated2026-09-09

简要摘要

This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。